A significant milestone for the Duchenne community in Scotland as a new treatment option due to become available on the NHS. We are delighted to …
Introducing Action Duchenne’s new CEO: Katie Endacott
We are delighted to introduce our new CEO, Katie Endacott and to share a statement from Vicky Pleydell, Chair of Trustees: "I am delighted to …
Introducing Action Duchenne’s new CEO: Katie EndacottRead More
Action Duchenne comment on statement from NorthStar Network UK about Givinostat
Action Duchenne comment on statement from NorthStar Network UK about Givinostat Firstly, and most importantly, our thoughts are with the families of …
Action Duchenne comment on statement from NorthStar Network UK about GivinostatRead More
Community Accessibility and Support
Community Accessibility and Support Our Community Accessibility and Support stream will run on Friday 14th November. It's designed to equip and …
DMD Care UK Nutrition Working Group – Online Focus Groups
This month there will be an opportunity for everyone interested in learning more about nutrition and Duchenne to participate in two online focus group …
DMD Care UK Nutrition Working Group – Online Focus GroupsRead More
Impact of NRS Healthcare Closure: Statement from the Chair of Action Duchenne, Vicky Pleydell
Urgent action needed to protect families affected by Duchenne muscular dystrophy I am deeply concerned about the devastating impact the collapse of …
World Duchenne Awareness Day 2025
Family: The Heart of Care September 7th marks World Duchenne Awareness Day. The 7th day of the 9th month in honour of the 79 exons on the …
Update from Roche regarding Delandistrogene Moxeparvovec (Elevidys)
On July 25th, Roche 5 the European Medicines Agency’s (EMA's) Committee for Human Medicinal Products (CHMP) unfortunately provided a negative opinion …
Update from Roche regarding Delandistrogene Moxeparvovec (Elevidys)Read More
Roche to resume Elevidys orders for ambulatory patients outside of the US
On July 29th, Roche announced its readiness to immediately resume new orders and shipments of Elevidys for ambulatory patients outside the United …
Roche to resume Elevidys orders for ambulatory patients outside of the US Read More
Entrada Therapeutics Shares Update on Duchenne Muscular Dystrophy (DMD) Programs
Entrada Therapeutics has released its financial results for the second quarter of 2025, which included important updates on its clinical programs for …
Entrada Therapeutics Shares Update on Duchenne Muscular Dystrophy (DMD) ProgramsRead More
Join us this World Duchenne Awareness Day
Join us this World Duchenne Awareness Day This year the theme for World Duchenne Awareness Day is “Family: The Heart Of Care”. This theme …
Roche Announces Temporary Pause to New Orders of Delandistrogene Moxeparvovec To Key Countries Outside the US.
Today (23rd of July), Roche issued a community update regarding its Duchenne program, specifically addressing the availability of delandistrogene …
